Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
uPAR–uPA Inhibition and Breast Cancer Metastasis
2026-08-25
Mani and colleagues combined chemical synthesis, direct binding assays, cellular invasion models, pharmacokinetics, and a mouse metastasis study to evaluate compound 4 as an inhibitor of the uPAR–uPA interaction. The work connects sub-micromolar receptor binding with reduced tumor-cell invasion and lung metastasis, while also identifying pharmacokinetic properties that guide further optimization.
-
EHEC Delays Precocious Puberty in Danazol Rat Models
2026-08-25
A 2025 study evaluated an Eclipta prostrata–Hordeum vulgare extract complex in rat models of precocious puberty induced by Danazol or a high-fat diet. The complex delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH mRNA elevation without altering body weight, supporting further investigation of hypothalamic–pituitary–gonadal axis modulation.
-
Drug-Sensitized Yeast for mTOR Inhibitor Discovery
2026-08-24
A 2025 GeroScience study develops a drug-sensitized Saccharomyces cerevisiae platform that detects TOR inhibitors at substantially lower concentrations than conventional yeast assays. The system distinguishes TOR1-dependent growth inhibition, identifies activity from established and previously unrecognized compounds, and provides a practical screening framework while clarifying why negative results for compounds such as canagliflozin should not be interpreted as evidence against their established non-TOR mechanisms.
-
EHEC Prevents Precocious Puberty in Danazol Rat Models
2026-08-24
A 2025 study tested an Eclipta prostrata–Hordeum vulgare extract complex in two rat models of precocious puberty induced by Danazol or a high-fat diet. The complex delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH mRNA elevation without altering body weight, supporting further investigation of hypothalamic–pituitary–gonadal axis modulation.
-
FITC Goat Anti-Rabbit IgG: Translational Insight
2026-08-23
A thought-leadership guide to using fluorescent secondary-antibody workflows to strengthen mechanistic validation of lycopene protection against DON-induced intestinal barrier dysfunction and NLRP3 activation.
-
BCLAF1–YTHDF2–SIX1 Axis in ESCC
2026-08-22
The reference study identifies a post-transcriptional mechanism in which BCLAF1 promotes esophageal squamous cell carcinoma by weakening YTHDF2-dependent degradation of m6A-modified SIX1 mRNA. Its integrated clinical, biochemical, transcriptomic, and in vivo evidence connects RNA stability with glycolysis, invasion, and tumor progression, providing a framework for mechanistic cancer research.
-
2'3'-cGAMP (sodium salt): Assay Guide
2026-08-22
This scenario-based guide explains how 2'3'-cGAMP (sodium salt), SKU B8362, can improve the design, handling, and interpretation of STING-pathway experiments linked to viability, proliferation, and cytotoxicity assays. It combines product specifications with mechanistic evidence on cGAMP hydrolysis by tumor-derived exosomal ENPP1.
-
PRV Infection, NF-κB, and AIM2 Signaling
2026-08-21
The reference study identifies a coordinated TLR2/TLR3/TLR4/TLR5–NF-κB response and AIM2 inflammasome pathway that drives cytokine production during pseudorabies virus infection in mice. Its main contribution is linking NF-κB-dependent cytokine priming with AIM2, ASC, caspase-1, and GSDMD-dependent cytokine release, while showing that this inflammatory program contributes to antiviral host defense.
-
Cyclopamine: Translating Hedgehog Biology
2026-08-20
A translational perspective on Cyclopamine as a Smoothened-directed Hedgehog signaling inhibitor, connecting developmental biology, cancer research, assay design, and strategic decision-making.
-
Retinoic Acid and Nutrient Restriction Trigger SSC Meiosis
2026-08-20
A Methods in Molecular Biology chapter by Zhang and Wang presents a culture strategy in which retinoic acid and nutrient restriction work together to initiate meiotic prophase I in long-term mouse spermatogonial stem cells. The approach addresses a persistent barrier in germline culture and provides a practical framework for studying meiotic entry without assuming that complete spermatogenesis has been achieved in vitro.
-
Cefotaxime as a Probe of AMR Transmission
2026-08-19
Cefotaxime can do more than benchmark antibacterial activity. Used alongside genotype, plasmid-mobility, and infection-model data, it helps translational researchers connect beta-lactam antibiotic mechanism with the evolving architecture of antimicrobial resistance.
-
JTW, Coptisine, and SIRT1 in PCOS Mitochondria
2026-08-19
A 2025 Phytomedicine study identifies suppression of SIRT1 ubiquitination as a mechanistic basis for the anti-PCOS activity of Jiao-tai-wan and its constituent coptisine. Using DHEA-induced PCOS rats and primary theca cells, the authors connect SIRT1 protein stability with mitochondrial cholesterol import, StAR localization, and abnormal ovarian steroidogenesis.
-
PDK4-IN-1 Hydrochloride: Mechanism & Uses
2026-08-18
PDK4-IN-1 hydrochloride is a selective, orally active pyruvate dehydrogenase kinase 4 inhibitor for research on PDH activation and mitochondrial energy metabolism. Product specifications and peer-reviewed findings support its use in in vitro metabolism studies and animal models, while distinguishing vendor-reported properties from evidence for lead compound 8c.
-
GDC-0994: Practical ERK1/2 Assay Guidance
2026-08-18
This scenario-based guide explains how GDC-0994 (SKU B5817) can support mechanistic studies of ERK-driven proliferation, viability, and cholestatic injury. It covers target engagement, solvent handling, dose design, orthogonal readouts, and practical criteria for selecting a reliable research reagent.
-
Ionomycin Free Acid: From Calcium Flux to TNBC Insight
2026-08-17
A translational framework for using Ionomycin free acid to interrogate calcium-dependent biology while connecting ionophore workflows with the FAISL–FAK proteolysis axis reported in triple-negative breast cancer.